MARKET

SURF

SURF

SURFACE ONCOLOGY
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.77
+0.10
+1.76%
Closed 16:00 07/10 EDT
OPEN
5.62
PREV CLOSE
5.67
HIGH
6.09
LOW
5.41
VOLUME
682.69K
TURNOVER
--
52 WEEK HIGH
7.66
52 WEEK LOW
1.150
MARKET CAP
163.42M
P/E (TTM)
-5.3150
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SURF stock price target is 10.33 with a high estimate of 12.00 and a low estimate of 9.00.

EPS

SURF News

More
3 Strong Buy Penny Stocks With Massive Upside Ahead
TipRanks · 06/12 14:45
Do Hedge Funds Love Surface Oncology, Inc. (SURF)?
In this article we will take a look at whether hedge funds think Surface Oncology, Inc. (NASDAQ:SURF) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of do
Insider Monkey · 06/11 00:12
Surface Oncology Announces Change to Location and Format of 2020 Annual Meeting of Stockholders
GlobeNewswire · 05/28 21:10
71 Biggest Movers From Friday
Gainers Inari Medical, Inc. (NASDAQ: NARI) shares surged 123.7% to close at $42.51 on Friday after pricing its IPO on Friday.
Benzinga · 05/26 08:30
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Benzinga · 05/24 18:40
Surface Oncology -2.1% after equity sales agreement
Surface Oncology (NASDAQ:SURF) is off 2.1% after hours following its entry into an at-the-market sales agreement with JonesTrading. That agreement covers o
seekingalpha · 05/23 03:56
64 Biggest Movers From Yesterday
Gainers
Benzinga · 05/22 09:26
Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.20% to 24526 while the NASDAQ fell 0.56% to 9323.26. The S&P also fell, dropping 0.51% to 2956.56.
Benzinga · 05/21 18:30

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About SURF

Surface Oncology, Inc. is a clinical-stage immuno-oncology company. The Company is engaged in the development of cancer immunotherapies. To unlock the potential of cancer immunotherapy, the Company is targeting a set of immune processes by which cancer cells evade immune recognition and attack. Its programs are built upon insights about how to improve the immune system’s recognition and elimination of cancer cells. These include approaches to improve the effectiveness of antigen presentation to the adaptive immune system, to block the activity of a range of suppressor cells in the tumor microenvironment, and to counter the immunosuppressive environment that selectively accumulates in and around the tumor. By targeting the interface of innate and adaptive immunity, it hopes to expand the reach of cancer immunotherapy to patients in need of treatment.
More

Webull offers kinds of Surface Oncology Inc stock information, including NASDAQ:SURF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SURF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SURF stock methods without spending real money on the virtual paper trading platform.